Mukul Deoras Sells 7,150 Shares of Colgate-Palmolive (CL) Stock

Colgate-Palmolive (NYSE:CL) insider Mukul Deoras sold 7,150 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $70.03, for a total value of $500,714.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Colgate-Palmolive (NYSE CL) traded up $0.92 during midday trading on Thursday, hitting $70.54. The company’s stock had a trading volume of 1,709,865 shares, compared to its average volume of 4,331,825. The company has a market capitalization of $61,140.00, a PE ratio of 30.89, a P/E/G ratio of 2.60 and a beta of 0.75. Colgate-Palmolive has a 52 week low of $68.03 and a 52 week high of $77.91. The company has a debt-to-equity ratio of 24.42, a current ratio of 0.47 and a quick ratio of 0.34.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.75. The company had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.75 earnings per share. sell-side analysts predict that Colgate-Palmolive will post 3.18 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.27%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 70.18%.

A number of large investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in Colgate-Palmolive by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after purchasing an additional 1,621,392 shares during the period. BlackRock Inc. grew its holdings in shares of Colgate-Palmolive by 1.4% during the 4th quarter. BlackRock Inc. now owns 52,360,691 shares of the company’s stock valued at $3,950,614,000 after acquiring an additional 711,972 shares in the last quarter. Renaissance Technologies LLC grew its holdings in shares of Colgate-Palmolive by 42.4% during the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after acquiring an additional 2,903,800 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 2.1% during the 4th quarter. Geode Capital Management LLC now owns 8,975,479 shares of the company’s stock valued at $675,751,000 after acquiring an additional 188,455 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its holdings in shares of Colgate-Palmolive by 25.3% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock valued at $508,111,000 after acquiring an additional 1,385,946 shares in the last quarter. 72.85% of the stock is currently owned by institutional investors.

CL has been the topic of several research reports. Citigroup cut their price objective on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research report on Thursday, November 2nd. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research report on Monday, October 23rd. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a research report on Tuesday, December 19th. Finally, Stifel Nicolaus set a $73.00 price target on Colgate-Palmolive and gave the stock a “hold” rating in a research note on Sunday, October 29th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the company’s stock. Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $77.71.

ILLEGAL ACTIVITY WARNING: “Mukul Deoras Sells 7,150 Shares of Colgate-Palmolive (CL) Stock” was originally published by Markets Daily and is owned by of Markets Daily. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.themarketsdaily.com/2018/02/15/mukul-deoras-sells-7150-shares-of-colgate-palmolive-cl-stock.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply